Mast Therapeutics (MSTX) Reports Q4 Loss of $0.02/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts MSTX Hot Sheet
Join SI Premium – FREE
Mast Therapeutics (NYSE: MSTX) reported Q4 EPS of ($0.02), versus ($0.06) reported last year.
For earnings history and earnings-related data on Mast Therapeutics (MSTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CPS Technologies (CPSH) Reports In-Line Q3 EPS
- Studio City International Holdings Limited (MSC) Reports Q3 Loss of $0.02
- Intel shares fall as competitor reports record results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
